Portage Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$75,339,000 over the previous period. Total operating expenses were $18,199,000.

Profit Margin

Portage Biotech Inc. (NASDAQ:PRTG): Profit margin
2015 0 -3.11M
2016 0 -5.70M
2017 0 16.29M
2018 0 123.74M
2019 0 -2.63M
2020 0 -7.24M
2021 0 -17.18M
2022 0 -19.16M
2023 0 -104.61M
2024 0 -75.33M

PRTG Income Statement (2015 โ€“ 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000000000
Cost of revenue
54K1K00000000
Gross profit
-54K-1K00000000
Operating exp.
Research and development
12.53M8.21M6.76M7.31M4.10M762K561K32.44M4.57M2.92M
Selling and marketing
0000000000
Total operating expenses
18.19M16.57M15.58M12.44M5.97M2.76M2.22M35.49M9.18M4.31M
Operating income
-18.25M-16.57M-15.58M-12.44M-5.97M-2.76M-2.22M-35.49M-9.18M-4.31M
Other income (expenses), net
-67.44M-105.94M771K-2.45M-549K-853K126M-552.42K-7.38K-115.84K
Income before tax
-85.69M-122.52M-14.81M-14.89M-5.08M-3.59M123.74M-641.27K-9.19M-4.34M
Income tax expense
-10.54M-17.85M4.35M2.29M2.16M-217K-126M-52.34M-3.48M-1.21M
Net income
-75.33M-104.61M-19.16M-17.18M-7.24M-2.63M123.74M16.29M-5.70M-3.11M
Earnings per share
Basic EPS
-3.7-6.49-1.47-1.47-0.66-0.5546.216.42-2.38-1.61
Diluted EPS
-3.7-6.49-1.47-1.47-0.66-0.5545.895.99-2.38-1.61
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source